METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Yu-Qing GuoQiang WangJun-Guo WangYa-Jun GuPan-Pan SongShou-Yu WangXiao-Yun QianXia GaoPublished in: Experimental hematology & oncology (2022)
METTL3 may be a potential prognostic biomarker and therapeutic target for HNSCC.
Keyphrases